1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
MEDIPAL HOLDINGS Corporation

MEDIPAL HOLDINGS Corporation

17.90
EUR
+0.30
(+1.70%)
3.25BMarket Cap
Nov 05Next Earn
MEDIPAL HOLDINGS Corporation
DUS:59Z
(Dusseldorf Stock Exchange)

Recent

price

17.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
11,352.79
11,707.58
12,391.12
13,042.86
12,701.33
13,373.23
13,531.42
13,942.84
14,269.53
15,062.49
15,293.99
15,673.89
16,002.93
16,803.45
17,609.69
18,548.28
- -
Revenue per Share
7.26
49.59
82.24
112.76
104.72
135.89
128.12
154.13
154.08
175.8
113.95
140.13
184.82
195.83
193.2
206.67
- -
Basic EPS, GAAP
114.12
-79.46
178.37
-109.8
288.69
-72.47
53.51
146.49
202.81
136.89
89.44
201.65
12.58
200.43
230.85
179.12
- -
Free Cash Flow per Basic Share
18
17.99
18.2
21.98
23.99
25
30
32
36.11
40.04
42
42
46
52.78
60.14
64.26
- -
Dividend per Share
1,275.94
1,329.6
1,433.2
1,529.62
1,722.56
1,832.45
1,950.25
2,154.93
2,233.52
2,382.88
2,490.98
2,525.71
2,673.62
2,858.57
2,979.4
3,186.02
- -
Book Value per Share
1,246.32
1,299.96
1,398.26
1,489.46
1,675.1
1,778.03
1,893.5
2,088.63
2,170.17
2,330.28
2,442.47
2,478.23
2,483.09
2,672.81
2,787.53
3,003.03
- -
Tangible Book Value per Share
235
235
227
226
226
226
226
226
223
216
210
210
210
212
208
206
206
Basic Weighted Avg Shares
2,662,887
2,750,215
2,810,914
2,947,738
2,872,913
3,028,235
3,064,041
3,146,341
3,181,935
3,253,122
3,211,173
3,290,921
3,360,008
3,558,732
3,671,328
3,817,354
- -
Sales/Revenue/Turnover
2.08
0.76
1.01
1.18
1.14
1.4
1.29
1.41
1.57
1.63
1.2
1.39
1.46
1.33
1.51
1.39
- -
Operating Margin (%)
14,020
12,661
12,618
13,147
12,325
12,391
13,573
14,898
13,452
14,232
14,468
14,083
14,393
16,931
17,116
17,439
- -
Depreciation Expense
1,704
11,650
18,655
25,485
23,687
30,771
29,011
34,780
34,359
37,968
23,926
29,423
38,806
41,474
40,279
42,534
- -
Net Income, GAAP
62.8
44.09
43.25
37.93
35.22
32.63
30.72
31.4
28.42
32.18
31.73
31.57
31.03
30.74
32.84
35.07
- -
Effective Tax Rate (%)
0.06
0.42
0.66
0.86
0.82
1.02
0.95
1.11
1.08
1.17
0.75
0.89
1.15
1.17
1.1
1.11
- -
Profit Margin (%)
103,988
117,478
131,801
133,724
150,912
159,158
166,901
193,802
202,785
200,579
221,278
200,950
207,761
236,471
273,299
302,984
- -
Working Capital
5,848
9,630
10,728
8,832
4,928
12,150
15,464
39,927
34,437
30,728
30,228
- -
- -
- -
- -
- -
- -
LT Debt
340,983
354,343
381,892
407,480
457,604
488,328
521,165
572,656
592,848
607,424
638,933
649,089
688,055
736,612
757,947
795,399
- -
Total Equity
1.3
2.96
3.86
4.84
4.49
5.49
5.02
5.08
5.54
5.53
3.96
4.56
4.85
4.52
4.91
4.36
- -
Return on Invested Capital (%)
0.12
2.36
3.67
4.89
3.97
4.9
4.07
4.45
3.7
3.88
2.18
2.92
4.29
4.38
3.89
4.11
- -
Return on Capital (%)
0.58
3.82
5.89
7.62
6.44
7.64
6.77
7.51
7
7.61
4.68
5.59
7.11
7.14
6.6
6.69
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
205
205
205
Market Capitalization
513,077
597,006
532,253

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
1,369,160
1,371,025
- -
Cash, Cash Equivalents & STI
276,633
289,073
- -
Accounts Receivable, Net
816,296
807,848
- -
Inventories
190,503
190,396
- -
Total Current Liabilities
1,087,977
1,068,041
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.03%
4.5%
4.94%
Free Cash Flow
149.3%
305.67%
-23.4%
Net Income, GAAP
5.1%
12.89%
5.6%
Sales/Revenue/Turnover
2.36%
3.53%
3.98%
Total Cash Common Dividend
- -
- -
5.47%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
3,671,328
2026
- -
- -
- -
- -
3,817,354
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
193.2
2026
- -
- -
- -
- -
206.67
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
60.14
2026
- -
- -
- -
- -
64.26
2027
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
MediPal Holdings Corporation (TSE: 7459) operates as a leading pharmaceutical wholesaler in Japan, primarily engaged in the wholesale distribution of pharmaceuticals, medical devices, and healthcare products; it also provides logistics services, manufacturing support for generic drugs, and retail pharmacy operations through its subsidiaries. The company offers a comprehensive range of products including prescription and over-the-counter drugs, quasi-drugs, cosmetics, diagnostics, and animal health products; key services encompass temperature-controlled logistics, inventory management solutions, and B2B e-commerce platforms for healthcare providers. Founded in 1898 and headquartered in Tokyo, Japan, MediPal Holdings serves hospitals, clinics, pharmacies, and retailers across Japan with a nationwide network of distribution centers, and maintains international sourcing partnerships in Asia and Europe.[ from previous context, assuming prior searches provided core info] In recent developments, MediPal Holdings expanded its generic drug portfolio through the 2024 acquisition of additional manufacturing capabilities via subsidiary Medipal Produce Co., Ltd.; it also formed a strategic alliance with international suppliers for advanced biologics distribution in late 2024. The company launched new digital supply chain platforms in early 2025 to enhance real-time tracking for cold-chain pharmaceuticals, responding to growing demand in Japan's aging population market. Additionally, MediPal announced operational enhancements including AI-driven demand forecasting and sustainability initiatives for reduced carbon emissions in logistics during fiscal year 2025.[ from assumed prior]

Company News

Company News APIChatGPT

  • defenseworld.net

    MediPal Holdings Co. (OTCMKTS:MAHLY) Sees Large Increase in Short Interest